Iterum Therapeutics

Company snapshot

Iterum Therapeutics plc is an Ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. These products are aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. Iterum’s first product is a novel anti-infective com

• 8 active pipeline program(s) linked via ClinicalTrials.gov.
• 3 US patent(s) indexed to this assignee profile.
• 8 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Iterum Therapeutics. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Iterum Therapeutics.

1. Jun 8, 2026 Clinical update

   Ertapenem — Phase 3

2. Jun 8, 2026 Clinical update

   Ciprofloxacin — Approved

3. Jun 8, 2026 Clinical update

   Azithromycin plus hydroxychloroquine — Phase 3

4. May 23, 2026 Clinical update

   Sulopenem — Phase 3

5. May 23, 2026 Clinical update

   Sulopenem etzadroxil/probenecid — Phase 3

View all clinical trial activity →

• What is Iterum Therapeutics?

  Iterum Therapeutics is a pharma organization headquartered in Dublin, IE. It trades on NYSE under ticker ITRMF. Primary therapeutic focus areas include Urinary Tract Infections, Respiratory Tract Infection Viral, UTI - Lower Urinary Tract Infection, Intra Abdominal Infections, Co

• Is Iterum Therapeutics publicly traded?

  Yes. Iterum Therapeutics is listed with ticker ITRMF on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Iterum Therapeutics develop or market?

  We link 8 drug profile(s) where Iterum Therapeutics is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/iterum-therapeutics-plc#company-drugs.

• What are the latest developments for Iterum Therapeutics?

  In the last 12 months our linked public records show 8 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Iterum Therapeutics focus on?

  Iterum Therapeutics focuses on Urinary Tract Infections, Respiratory Tract Infection Viral, UTI - Lower Urinary Tract Infection based on our analysis of their pipeline programs and drug development activities.